Prof Kumar Visvanathan
Professor Infectious Diseases
Department of Medicine
293 Scholarly works
20 Projects
HIGHLIGHTS
2026
Journal article
Monocyte Distribution Width Differentiates Bacterial Enterocolitis from Acute Severe Ulcerative Colitis in the Emergency Department
DOI: 10.1007/s10620-026-09786-w2026
Journal article
SAT-562 End-of-treatment biomarkers and HBV genotype predict severe biochemical flares after nucleos(t)ide analogue cessation: individual patient level meta-analysis of five prospective studies within the PROSTOP consortium
DOI: 10.1016/s0168-8278(26)02414-12026
Journal article
OS-101-YI Association between end-of-treatment biomarkers and HBV genotype in severe biochemical flares after nucleos(t)ide analogue cessation: results from five prospective studies within the PROSTOP consortium
DOI: 10.1016/s0168-8278(26)00412-52026
Journal article
Anti-HBs Immune Complex Levels: A Novel Marker of Hepatitis Flare Following Nucleos(t)ide Analog Withdrawal in HBeAg-negative Chronic Hepatitis B
DOI: 10.1093/infdis/jiaf5692023
Research grants (ARC, NHMRC, MRFF)
Novel Monoclonal Antibodies to Treat Chronic Hepatitis B
2023
Research Grant
Novel Monoclonal Antibodies to Treat Chronic Hepatitis B
2018
Research Grant
Novel Early Detection Strategy for Liver Cancer Using Hepatitis B Splice Variants to Expediate Diagnosis and Improve Treatment Outcome
RECENT SCHOLARLY WORKS
2026
Journal article
Long-Term Follow-Up of Patients in a Prospective Study of NA Discontinuation Identifies Different Patterns of HBsAg Loss
DOI: 10.1111/apt.703322026
Journal article
Early Infliximab Levels and Clearance Predict Outcomes After Infliximab Rescue in Acute Severe Ulcerative Colitis: Results From PREDICT-UC
DOI: 10.1053/j.gastro.2025.07.0202025
Journal article
Effective real-world outcomes of remdesivir provided under compassionate access for moderate/severe COVID-19 in Australia
DOI: 10.1111/imj.701732025
Journal article
Su1880: EARLY SERUM AND FAECAL CYTOKINES PREDICT CLINICAL OUTCOMES IN ACUTE SEVERE ULCERATIVE COLITIS: RESULTS FROM PREDICT-UC
DOI: 10.1016/s0016-5085(25)02941-52025
Journal article
DOP057 Early serum and faecal cytokines predict clinical outcomes in Acute Severe Ulcerative Colitis: results from PREDICT-UC
DOI: 10.1093/ecco-jcc/jjae190.00962025
Journal article
DOP091 Early serum infliximab levels predict outcomes in Acute Severe Ulcerative Colitis: results from PREDICT-UC
DOI: 10.1093/ecco-jcc/jjae190.0130
RECENT PROJECTS
2023
Research Grant
Novel Monoclonal Antibodies to Treat Chronic Hepatitis B
2020
Research Contracts
Testing Immune-Mobilising Monoclonal T-Cell Receptors in Chronic Hepatitis B Patient-Derived Liver Organoids